Bolt Biotherapeutics, Inc.

BOLT

Bolt Biotherapeutics, Inc.

BOLT

Insider Sentiment (TTM):

Last Purchase:2025-12-05Last Sale:2023-11-30Shares Purchased (TTM):250Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:613,210Shares Outstanding:1,680,445Institutional Ownership Pct.:36.49%

Earnings Market Reaction:

Filing Date:2026-05-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Bolt Biotherapeutics, Inc. (BOLT) — SEC Financial Statements & Analysis

Bolt Biotherapeutics, Inc. (BOLT) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	12	12	18	10	8	7	9	6	4	11	9	13
Short Term Investments	11	16	14	25	30	40	44	67	87	91	111	112
Assets Current
Assets Current	26	30	36	38	43	51	57	77	95	106	125	131
Restricted Cash Current	0	0	1	1	1	1	1	-	-	0	-	-
Prepaid Expense And Other Assets Current	3	3	3	3	3	3	3	3	4	4	6	5
Property Plant And Equipment Net	1	1	2	2	2	3	4	4	4	5	5	6
Operating Lease Right Of Use Asset	19	19	20	21	21	22	17	18	18	19	20	21
Restricted Cash Noncurrent	2	2	1	1	1	1	1	2	2	2	2	2
Long Term Investments	1	4	7	14	19	23	31	24	21	26	22	31
Other Assets Noncurrent	0	0	0	0	0	0	0	0	2	2	1	1
Assets	48	57	65	75	86	100	109	124	143	160	175	191
Liabilities And Stockhold…
Accounts Payable Current	2	1	2	2	2	2	1	3	2	3	4	3
Liabilities Current
Deferred Revenue Current	1	0	2	3	3	3	2	2	2	2	2	2
Liabilities Current	7	8	10	12	14	16	18	18	17	20	19	18
Operating Lease Liability Current	3	3	3	3	2	2	3	3	3	3	3	3
Operating Lease Liability Noncurrent	19	20	21	22	22	23	15	16	17	17	18	19
Deferred Revenue Noncurrent	1	2	2	3	3	4	4	5	5	9	10	12
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	28	30	33	37	39	42	37	38	39	47	47	49
Preferred Stock Value	-	-	-	-	-	-	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	20	27	32	39	47	57	72	86	104	113	128	142
Additional Paid In Capital Common Stock	488	487	486	486	485	485	483	482	479	477	475	472
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	0	0	0	-0	-0	0	-0	-0
Retained Earnings Accumulated Deficit	-468	-461	-454	-447	-438	-427	-411	-396	-375	-364	-346	-330
Liabilities And Stockholders Equity	48	57	65	75	86	100	109	124	143	160	175	191
Preferred Stock Par Or Stated Value Per Share	-	-	-	-	-	-	0	0	0	0	0	0
Preferred Stock Shares Authorized	-	-	-	-	-	-	10	10	10	10	10	10
Preferred Stock Shares Issued	-	-	-	-	-	-	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	-	-	-	-	-	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	2	2	2	2	38	2	38	38	38	38	38	38
Shares Outstanding	2	2	2	2	2	2	2	2	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.60%	-15.27%	-	-	-	-	-	-	-	-	-	-
2025	-12.70%	-20.00%	-25.27%	-4.60%	-2.39%	5.88%	15.57%	23.45%	25.80%	5.93%	24.94%	29.63%
2024	-42.35%	-45.38%	-44.09%	-7.43%	-7.86%	-5.86%	-9.03%	-8.41%	-23.68%	-20.09%	-33.11%	-30.37%
2023	-	-	-	-16.28%	-19.38%	-26.36%	-9.18%	14.29%	9.18%	3.45%	8.62%	-34.40%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.51	3.59	3.57	3.11	3.13	3.20	3.16	4.28	5.68	5.17	6.69	7.42
Quick Ratio	3.14	3.28	3.28	2.89	2.92	3.03	3.02	4.12	5.46	5.00	6.38	7.14
Working Capital	18.41M	21.83M	25.64M	26.03M	28.95M	34.96M	39.06M	58.73M	78.33M	85.25M	106.72M	113.05M
Leverage & Debt
Debt to Equity	1.42	1.14	1.03	0.94	0.83	0.74	0.52	0.45	0.37	0.42	0.37	0.34
Debt Ratio	0.59	0.53	0.51	0.49	0.45	0.43	0.34	0.31	0.27	0.29	0.27	0.25
Efficiency & Turnover
Asset Turnover TTM	0.10	0.10	0.06	0.04	0.03	0.06	0.07	0.07	0.06	0.04	0.03	0.03
Per Share Metrics
Diluted EPS TTM	-17.60	-17.85	-22.24	-26.45	-33.05	-33.06	-34.03	-34.71	-33.11	-36.60	-37.65	-40.68
Free Cash Flow Per Share TTM	-20.58	-21.35	-24.59	-26.80	-30.23	-32.12	-31.98	-33.61	-33.14	-36.88	-38.87	-37.55
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-486.21%	-469.30%	-884.39%	-1,312.31%	-1,871.11%	-949.91%	-776.13%	-695.31%	-661.19%	-967.45%	-1,076.27%	-1,203.67%
Net Profit Margin TTM	-455.15%	-433.74%	-821.58%	-1,217.01%	-1,741.26%	-820.78%	-665.56%	-592.57%	-556.59%	-878.58%	-990.43%	-1,132.31%
Growth Metrics
Net Revenue Growth (1Y)	78.64%	0.07%	-46.88%	-62.68%	-67.87%	-2.36%	35.86%	64.64%	67.96%	37.48%	49.15%	95.67%
Net Income Growth (1Y)	-53.30%	-47.12%	-34.42%	-23.35%	0.51%	-8.79%	-8.71%	-13.84%	-22.57%	-21.45%	-25.16%	-20.75%
EPS Growth (1Y)	-46.73%	-46.01%	-34.66%	-23.80%	-0.20%	-9.67%	-9.62%	-14.70%	-23.35%	-22.40%	-25.98%	-21.70%
Valuation Metrics
P/E TTM	-0.23	-0.31	-0.24	-0.22	-0.24	-0.32	-0.38	-0.43	-0.85	-0.61	-0.55	-0.63
P/B	0.34	0.39	0.32	0.28	0.33	0.36	0.34	0.33	0.51	0.38	0.31	0.34
P/S TTM	1.04	1.33	1.97	2.66	4.22	2.66	2.53	2.56	4.71	5.38	5.47	7.12
Market Cap	6.79M	10.22M	10.21M	11.06M	15.34M	20.43M	24.79M	28.60M	53.30M	42.35M	39.38M	48.32M
Enterprise Value	-6.56M	-3.22M	-9.31M	-301.28K	5.18M	13.22M	13.65M	22.40M	49.03M	29.77M	28.46M	34.87M
Calculated Values
Free Cash Flow TTM	-34.58M	-39.92M	-47.20M	-51.40M	-57.94M	-61.33M	-61.17M	-64.08M	-63.08M	-69.73M	-73.60M	-70.87M
Net Debt	-13.35M	-13.44M	-19.52M	-11.37M	-10.16M	-7.21M	-11.14M	-6.20M	-4.26M	-12.58M	-10.93M	-13.45M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-05Purchase

Owner: Nemec, Sarah

Title: Senior VP, Finance and PAO

Shares: 125

Price/Share: $4.61

Value: $576.25

Shares Owned: 1,415

Relationship: Officer

Ownership: Direct

2025-12-05Purchase

Owner: Quinn, William P.

Title: President, CEO and CFO

Shares: 125

Price/Share: $4.61

Value: $576.25

Shares Owned: 2,313

Relationship: Director,Officer

Ownership: Direct

2025-06-06Purchase

Owner: Nemec, Sarah

Title: Senior VP, Finance and PAO

Shares: 125

Price/Share: $5.49

Value: $686.25

Shares Owned: 943

Relationship: Officer

Ownership: Direct

2025-06-06Purchase

Owner: Quinn, William P.

Title: President, CEO and CFO

Shares: 125

Price/Share: $5.49

Value: $686.25

Shares Owned: 2,188

Relationship: Director,Officer

Ownership: Direct

2024-12-16Purchase

Owner: Quinn, William P.

Title: President, CEO and CFO

Shares: 2,500

Price/Share: $0.50

Value: $1,250.00

Shares Owned: 41,272

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-05	Nemec, Sarah	Officer	Senior VP, Finance and PAO	Direct	Purchase	125	4.61	$576.25	1,415	4
2025-12-05	Quinn, William P.	Director,Officer	President, CEO and CFO	Direct	Purchase	125	4.61	$576.25	2,313	4
2025-06-06	Nemec, Sarah	Officer	Senior VP, Finance and PAO	Direct	Purchase	125	5.49	$686.25	943	4
2025-06-06	Quinn, William P.	Director,Officer	President, CEO and CFO	Direct	Purchase	125	5.49	$686.25	2,188	4
2024-12-16	Quinn, William P.	Director,Officer	President, CEO and CFO	Direct	Purchase	2,500	0.50	$1,250.00	41,272	4
2024-12-16	Nemec, Sarah	Officer	Senior VP, Finance and PAO	Direct	Purchase	2,500	0.50	$1,250.00	16,633	4
2023-12-12	Quinn, William P.	Officer	Chief Financial Officer	Direct	Purchase	7,500	0.95	$7,125.00	36,272	4
2023-12-06	Schatzman, Randall C	Director,Officer	Chief Executive Officer	Direct	Purchase	2,500	0.78	$1,950.00	12,859	5
2023-12-06	Yonehiro, Grant	Officer	Chief Business Officer	Direct	Purchase	2,500	0.78	$1,950.00	8,918	5
2023-12-06	Perez, Edith A.	Officer	Chief Medical Officer	Direct	Purchase	2,500	0.78	$1,950.00	46,612	5
2023-11-30	Engleman, Edgar	Director	-	Indirect	Sale	123,079	0.86	$105,847.94	251,522	4
2023-11-21	Engleman, Edgar	Director	-	Indirect	Sale	1,943	0.90	$1,748.70	269,587	4
2023-11-21	Vivo, Capital Viii, Llc, …	TenPercentOwner	-	Indirect	Sale	3,400	0.90	$3,060.00	111,662	4
2023-11-20	Vivo, Capital Surplus Fun…	TenPercentOwner	-	Indirect	Sale	54,700	0.92	$50,324.00	113,119	4
2023-11-20	Engleman, Edgar	Director	-	Indirect	Sale	31,257	0.92	$28,756.44	269,823	4
2022-12-06	Schatzman, Randall C	Director,Officer	Chief Executive Officer	Direct	Purchase	2,500	1.18	$2,950.00	7,859	5
2022-12-06	Quinn, William P.	Officer	Chief Financial Officer	Direct	Purchase	1,789	1.18	$2,111.02	24,443	5
2022-12-06	Yonehiro, Grant	Officer	Chief Business Officer	Direct	Purchase	2,500	1.18	$2,950.00	6,418	5
2022-12-06	Perez, Edith A.	Officer	Chief Medical Officer	Direct	Purchase	2,500	1.18	$2,950.00	42,042	5
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

36.49%

Inst. Shares: 613,210

Shares Outstanding: 1,680,445

2025-12-31

32.22%

Inst. Shares: 602,538

Shares Outstanding: 1,869,924

2025-09-30

41.89%

Inst. Shares: 804,036

Shares Outstanding: 1,919,441

2025-06-30

46.28%

Inst. Shares: 887,524

Shares Outstanding: 1,917,629

2025-03-31

47.76%

Inst. Shares: 915,517

Shares Outstanding: 1,916,943

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	613,210	1,680,445	36.49%
2025-12-31	602,538	1,869,924	32.22%
2025-09-30	804,036	1,919,441	41.89%
2025-06-30	887,524	1,917,629	46.28%
2025-03-31	915,517	1,916,943	47.76%
2024-12-31	932,026	1,909,225	48.82%
2024-09-30	939,109	1,912,554	49.10%
2024-06-30	1,131,287	1,906,496	59.34%
2024-03-31	1,173,667	1,903,421	61.66%
2023-12-31	1,184,049	1,890,599	62.63%
2023-09-30	1,211,434	1,893,424	63.98%
2023-06-30	1,234,983	1,887,520	65.43%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Bolt Biotherapeutics, Inc. (BOLT) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.